Posted by Defense World Staff on Jul 9th, 2024
Wolfe Research began coverage on shares of Equifax (NYSE:EFX – Get Free Report) in a report issued on Tuesday, Briefing.com reports. The firm set an “outperform” rating and a $275.00 price target on the credit services provider’s stock. Wolfe Research’s target price would indicate a potential upside of 13.97% from the stock’s current price.
Other analysts have also issued reports about the company. Robert W. Baird cut their price target on Equifax from $275.00 to $260.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Oppenheimer reduced their price objective on Equifax from $291.00 to $272.00 and set an “outperform” rating for the company in a research note on Friday, April 19th. The Goldman Sachs Group reduced their price objective on Equifax from $276.00 to $241.00 and set a “neutral” rating for the company in a research note on Friday, April 19th. Bank of America cut their target price on Equifax from $300.00 to $255.00 and set a “buy” rating on the stock in a research report on Friday, April 19th. Finally, JPMorgan Chase & Co. cut their target price on Equifax from $290.00 to $273.00 and set an “overweight” rating on the stock in a research report on Friday, April 19th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Equifax currently has an average rating of “Moderate Buy” and an average target price of $270.47.
Check Out Our Latest Stock Report on Equifax
Equifax Stock Performance
NYSE:EFX opened at $241.30 on Tuesday. The stock’s 50-day simple moving average is $238.16 and its 200 day simple moving average is $246.31. The firm has a market capitalization of $29.83 billion, a PE ratio of 53.74, a price-to-earnings-growth ratio of 1.69 and a beta of 1.56. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 1.04. Equifax has a twelve month low of $159.95 and a twelve month high of $275.10.
Equifax (NYSE:EFX – Get Free Report) last released its quarterly earnings data on Thursday, April 18th. The credit services provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.06. The business had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.40 billion. Equifax had a return on equity of 19.08% and a net margin of 10.42%. Equifax’s revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $1.43 earnings per share. On average, analysts anticipate that Equifax will post 7.37 EPS for the current fiscal year.
Insiders Place Their Bets
In other Equifax news, EVP Rodolfo O. Ploder sold 14,097 shares of the company’s stock in a transaction dated Friday, April 26th. The stock was sold at an average price of $225.45, for a total value of $3,178,168.65. Following the transaction, the executive vice president now directly owns 75,964 shares in the company, valued at approximately $17,126,083.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP James M. Griggs sold 2,410 shares of the company’s stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $238.60, for a total value of $575,026.00. Following the completion of the transaction, the senior vice president now directly owns 5,001 shares in the company, valued at approximately $1,193,238.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Rodolfo O. Ploder sold 14,097 shares of the company’s stock in a transaction dated Friday, April 26th. The stock was sold at an average price of $225.45, for a total value of $3,178,168.65. Following the completion of the transaction, the executive vice president now owns 75,964 shares of the company’s stock, valued at $17,126,083.80. The disclosure for this sale can be found here. Insiders have sold 83,635 shares of company stock worth $18,969,282 in the last ninety days. 1.66% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Equifax
A number of hedge funds and other institutional investors have recently modified their holdings of EFX. Thompson Investment Management Inc. boosted its holdings in Equifax by 0.3% during the 2nd quarter. Thompson Investment Management Inc. now owns 15,464 shares of the credit services provider’s stock valued at $3,749,000 after acquiring an additional 45 shares during the period. DNB Asset Management AS boosted its holdings in Equifax by 6.8% during the 2nd quarter. DNB Asset Management AS now owns 23,850 shares of the credit services provider’s stock valued at $5,783,000 after acquiring an additional 1,517 shares during the period. Massmutual Trust Co. FSB ADV boosted its holdings in Equifax by 16.0% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 507 shares of the credit services provider’s stock valued at $123,000 after acquiring an additional 70 shares during the period. GAMMA Investing LLC boosted its holdings in Equifax by 91.3% during the 2nd quarter. GAMMA Investing LLC now owns 1,871 shares of the credit services provider’s stock valued at $454,000 after acquiring an additional 893 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its holdings in Equifax by 15.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 1,791 shares of the credit services provider’s stock valued at $479,000 after acquiring an additional 240 shares during the period. 96.20% of the stock is currently owned by hedge funds and other institutional investors.
About Equifax
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Articles
- Five stocks we like better than Equifax
- 3 Healthcare Dividend Stocks to Buy
- Greenbrier Companies Stock Enters Buy Zone – Opportunity Knocks
- ESG Stocks, What Investors Should Know
- Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
- 3 Best Fintech Stocks for a Portfolio Boost
- Get Ready: 3 High Short Interest Stocks Poised for a Melt-Up
Receive News & Ratings for Equifax Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Equifax and related companies with MarketBeat.com’s FREE daily email newsletter.
You might be interested in:
